Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Blood|October 1, 1993
6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphomaK Offit, N Z Parsa, G Gaidano, et al.
Leukemia & Lymphoma|December 1, 1995
BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphomaK Offit, D C Louie, N Z Parsa, et al.
Breast Cancer Research and Treatment|November 4, 2009
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2S M Domchek, M M Gaudet, J E Stopfer, et al.
Blood|October 1, 1992
Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphomaG Gaidano, R S Hauptschein, N Z Parsa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2001
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutationsN D Kauff, L Scheuer, M E Robson, et al.
Journal of the National Cancer Institute|December 22, 1999
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutationsM Robson, D Levin, M Federici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Identification of genetic lesions associated with diffuse large-cell lymphomaR Dalla-Favera, B H Ye, F Lo Coco, et al.
Genetic Testing|January 1, 1997
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancerM Robson, M K Dabney, G Rosenthal, et al.
Pageof 9